Akari Therapeutics (AKTX) EPS (Basic) (2014 - 2026)
Akari Therapeutics (AKTX) reported EPS (Basic) of -$0.0 for Q1 2026, up 95.52% on a YoY basis from -$0.0 in Q1 2025, and up 96.13% sequentially from -$0.0 in Q4 2025.
Akari Therapeutics (AKTX) EPS (Basic) (2014 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has 9 years of EPS (Basic) data on file, last reported at -$0.0 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 95.52% year-over-year to -$0.0; the trailing twelve-month figure through Mar 2026 stood at -$0.0 (up 98.11% YoY), and the FY2025 full-year result was -$0.01, up 68.99% from the prior year.
- EPS (Basic) grew to -$0.0 in Q1 2026, from -$0.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q1 2026 to a low of -$0.02 in Q1 2023.
- A 4-year average of -$0.01 and a median of -$0.01 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) rose 12.8% in 2024 and jumped 95.52% in 2026, its largest moves.
- Tracing AKTX's EPS (Basic) over 4 years: stood at -$0.02 in 2023, then soared by 69.7% to -$0.01 in 2024, then surged by 50.17% to -$0.0 in 2025, then soared by 96.13% to -$0.0 in 2026.
- Business Quant data shows AKTX's EPS (Basic) at -$0.0 in Q1 2026, -$0.0 in Q4 2025, and -$0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.02 |
| Mar 31, 2024 | -0.02 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2020 | -1.74 |
| Sep 30, 2020 | -0.06 |
| Jun 30, 2020 | -1.71 |
| Mar 31, 2020 | -1.57 |
| Dec 31, 2019 | -3.42 |
| Sep 30, 2019 | -1.45 |
| Jun 30, 2019 | -3.03 |